Fidelity Investments’s Lisata Therapeutics LSTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12 Buy
+8
New +$15 ﹤0.01% 5706
2023
Q3
– Sell
-1
Closed -$3 – 5431
2023
Q2
$4 Hold
1
– – ﹤0.01% 5323
2023
Q1
$3 Hold
1
– – ﹤0.01% 5229
2022
Q4
$2 Hold
1
– – ﹤0.01% 5317
2022
Q3
$5 Buy
+1
New +$7 ﹤0.01% 5266
2021
Q1
– Hold
0
– – – 4311
2020
Q4
– Hold
0
– – – 4109
2020
Q2
– Sell
-27
Closed -$1K – 3936
2020
Q1
$1K Buy
+27
New +$1.05K ﹤0.01% 3503

Other funds holding LSTA

Fidelity Investments's LSTA Position: Q3 2026 in Review

Fidelity Investments opened a new position in Lisata Therapeutics (LSTA) in Q3 2026: 8 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #5706 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in LSTA as recently as Q2 2023.

Fidelity Investments first reported a position in LSTA in Q1 2020 and has held it in 6 quarters since. The position peaked at $1K in Q1 2020. 39 funds tracked by Wall St. Rank hold LSTA as of Q3 2026.

  • Fidelity Investments held 8 shares of Lisata Therapeutics worth $12 as of Q3 2026.
  • Lisata Therapeutics was a new Fidelity Investments position in Q3 2026.
  • Lisata Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #5706 holding.
  • Fidelity Investments first reported a position in Lisata Therapeutics in Q1 2020 and has held it in 6 quarters since.
  • Fidelity Investments's Lisata Therapeutics position peaked at $1K in Q1 2020.
  • 39 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.